Dr. Teresa Macarulla

Dr. Teresa Macarulla is a highly accomplished medical professional with a strong background in oncology research and clinical practice. She obtained her medical degree from the Faculty of Medicine at the Autonomous University of Barcelona in Spain, completing her studies from 1992 to 1998. Following her medical education, Dr. Macarulla pursued a residency in the Department of Medical Oncology at the University Hospital Sant Pau, Autonomous University of Barcelona, from 2000 to 2004. From 2004... to 2016, Dr. Macarulla served as an Attending Physician in the Gastrointestinal Tumors Service and Medical Oncology Service at the University Hospital of Vall d'Hebron in Barcelona. Her work primarily focused on the treatment and care of patients with gastrointestinal tumors, including colon, gastric, pancreatic, biliary, and esophageal cancers. In 2007, Dr. Macarulla participated in the Clinical Exchange Program at the Memorial Sloan Kettering Cancer Center in New York, United States, further expanding her knowledge and expertise in the field of oncology. Since 2016, Dr. Macarulla has held the position of Head of the Gastrointestinal and Endocrine Tumor Unit and Principal Investigator at the Vall d'Hebron Institute of Oncology. In this role, she leads a team focused on studying and treating gastrointestinal and endocrine tumors, while also conducting important research in the field. Dr. Macarulla is an active member of various medical and scientific societies, including the American Society of Clinical Oncology, the European Society for Medical Oncology, and the Spanish Society of Medical Oncology. Her involvement in these societies highlights her dedication to staying up-to-date with the latest advancements in oncology research and treatment. Dr. Macarulla's research interests span both clinical and pre-clinical investigations. In her clinical work, she focuses on participating in and designing clinical trials for gastrointestinal tumors, with a particular emphasis on colon, gastric, pancreatic, biliary, and esophageal cancers. Her aim is to improve patient outcomes through the development of novel treatment approaches and the identification of prognostic and predictive factors. In the realm of pre-clinical investigation, Dr. Macarulla is particularly interested in the development of medications and phase I clinical trials for solid tumors. Her research focuses on molecularly targeted therapies, with a special emphasis on determining the optimal biological dose based on pharmacokinetic and pharmacodynamic analyses. She also investigates molecular biomarkers to identify predictors of clinical efficacy in phase I trials. One of Dr. Macarulla's ongoing projects is the investigation of molecular biomarkers in gastrointestinal tumors. This research aims to enhance the understanding of prognostic and predictive factors related to response and efficacy in various types of gastrointestinal cancers. Dr. Teresa Macarulla's contributions to the field of oncology are substantial, with over 210 publications to her name.